Physician profile
Eric A Beane
NPI 1154913309
$1,112.85
in general payments reported to CMS, 2019-2025
15 companies · $229 in 2025
The $229 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $106 · 2022: $318 · 2023: $191 · 2024: $270 · 2025: $229.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $689.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $689.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $219.30 | 2024-2025 | Proclaim |
| Abbvie INC. | $169.35 | 2023-2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $143.36 | 2022 | |
| Novo Nordisk INC | $121.83 | 2025 | Ozempic |
| Pfizer INC. | $105.75 | 2023 | |
| Collegium Pharmaceutical, INC. | $75.95 | 2021-2022 | |
| Grt US Holding, INC. | $57.73 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $56.45 | 2022 | |
| Scilex Pharmaceuticals INC. | $32.24 | 2021-2022 | |
| Spr Therapeutics, INC | $29.33 | 2024 | Sprint Pns System |
| Biohaven Pharmaceuticals, INC. | $25.22 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $24.31 | 2024 | Iovera |
| Bioventus LLC | $20.52 | 2021 | |
| Medtronic, INC. | $19.51 | 2024 | Intellis Adaptivestim |
| Hikma Pharmaceuticals USA | $12.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Beane listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.